• Article

Evaluation of risk minimisation activities for cyproterone acetate 2 mg/ethinylestradiol 35 mu g

Citation

Davis, K. H., Asiimwe, A., Zografos, L. J., McSorley, D. J., & Andrews, E. (2016). Evaluation of risk minimisation activities for cyproterone acetate 2 mg/ethinylestradiol 35 mu g. Pharmacoepidemiology and Drug Safety, 25(S3), 309-310. DOI: 10.1002/pds.4070

DOI Links